Treatment with bortezomib (PS-341) of Golden Retriever Muscular Dystrophy (GRMD): analysis of proteasome inhibition and morphology of dystrophic skeletal muscle (2009)
- Authors:
- USP affiliated authors: MIGLINO, MARIA ANGÉLICA - FMVZ ; GORNIAK, SILVANA LIMA - FMVZ ; BELIZARIO, JOSE ERNESTO - ICB ; AMBROSIO, CARLOS EDUARDO - FZEA
- Unidades: FMVZ; ICB; FZEA
- DOI: 10.1016/j.nmd.2009.06.218
- Subjects: FARMACOLOGIA; CÃO GOLDEN RETRIEVER; DISTROFIA MUSCULAR ANIMAL; NEUROLOGIA VETERINÁRIA
- Language: Inglês
- Imprenta:
- Publisher: Elsevier Science
- Publisher place: Oxford
- Date published: 2009
- Source:
- Título do periódico: Neuromuscular Disorders
- ISSN: 0960-8966
- Volume/Número/Paginação/Ano: v. 19, n. 8-9, p. 613, res. T.P.4.03, Sept. 2009
- Conference titles: International Congress of the World Muscle Society
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
ARAÚJO, Karla Patrícia Cardoso et al. Treatment with bortezomib (PS-341) of Golden Retriever Muscular Dystrophy (GRMD): analysis of proteasome inhibition and morphology of dystrophic skeletal muscle. Neuromuscular Disorders. Oxford: Elsevier Science. Disponível em: https://doi.org/10.1016/j.nmd.2009.06.218. Acesso em: 19 mar. 2024. , 2009 -
APA
Araújo, K. P. C., Moreira, D. F., Gaiad, T. P., Miglino, M. A., Górniak, S. L., Feder, D., et al. (2009). Treatment with bortezomib (PS-341) of Golden Retriever Muscular Dystrophy (GRMD): analysis of proteasome inhibition and morphology of dystrophic skeletal muscle. Neuromuscular Disorders. Oxford: Elsevier Science. doi:10.1016/j.nmd.2009.06.218 -
NLM
Araújo KPC, Moreira DF, Gaiad TP, Miglino MA, Górniak SL, Feder D, Belizário JE, Ambrósio CE. Treatment with bortezomib (PS-341) of Golden Retriever Muscular Dystrophy (GRMD): analysis of proteasome inhibition and morphology of dystrophic skeletal muscle [Internet]. Neuromuscular Disorders. 2009 ; 19( 8-9): 613.[citado 2024 mar. 19 ] Available from: https://doi.org/10.1016/j.nmd.2009.06.218 -
Vancouver
Araújo KPC, Moreira DF, Gaiad TP, Miglino MA, Górniak SL, Feder D, Belizário JE, Ambrósio CE. Treatment with bortezomib (PS-341) of Golden Retriever Muscular Dystrophy (GRMD): analysis of proteasome inhibition and morphology of dystrophic skeletal muscle [Internet]. Neuromuscular Disorders. 2009 ; 19( 8-9): 613.[citado 2024 mar. 19 ] Available from: https://doi.org/10.1016/j.nmd.2009.06.218 - Bortezomib (PS-341) treatment decreases inflammation and partially rescues the expression of the dystrophin- glycoprotein complex in GRMD dogs
- Presumed normal ultrasonographic findings of the testis and epididymis of botos (Inia geoffrensis)
- Gross morphology of rhea oropharyngeal cavity
- Marsupial morphology of reproduction: South America opossum male model
- Review point on neural stem cells and neurogenic areas of the central nervous system
- Histological comparison of the smooth uterine muscle of healthy golden retriever bitches, carriers of the progressive muscular dystrophy (GRMD) gene, and GRMD-affected bitches
- In vitro development of bovine cloned embryos produced by handmade cloning from distinct cell culture confluences and aggregation schemes
- Radiologic images at thoracic cavity of Golden Retriever dogs affected by muscular dystrophy
- Morphological and ultrastructural analysis of the tongue of Gracilinanus microtarsus (Wagner, 1842)
- Animal-assisted therapy in early childhood schools in São Paulo, Brazil
Informações sobre o DOI: 10.1016/j.nmd.2009.06.218 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas